See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2023_ANI_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 344,261,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 279,856,000 |
| 2 | PropertyPlantAndEquipmentNet | 43,246,000 |
| 3 | remainder_Assets | 92,724,000 |
| 4 | LiabilitiesCurrent | 99,439,000 |
| 5 | LiabilitiesNoncurrent | 287,050,000 |
| 6 | remainder_Liabilities | 35,058,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 124,044,000 |
| 9 | ResearchAndDevelopmentExpense | 22,318,000 |
| 10 | remainder_Expenses | 190,537,000 |
| 11 | remainder_Revenues | 316,385,000 |
| 12 | remainder_NetIncome | -27,382,000 |
| 13 | remainder_ComprehensiveNetIncome | 15,223,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 760,087,000 |
| 1 | Liabilities | 421,547,000 |
| 2 | Expenses | 336,899,000 |
| 3 | Revenues | 316,385,000 |
| 4 | StockholdersEquity | 338,540,000 |
| 5 | NetIncome | -47,896,000 |
| 6 | ComprehensiveNetIncome | -40,284,500 |
| 7 | BaseVar | 938,761,500 |
| 8 | EconomicCapitalRatio | 0.917 |
Edgar->Model Mapping
Feature Distribution
Change over Time
